The history of haploidentical stem cell transplantation: a trip from the bench to the bedside

Abstract

ABSTRACTAllogeneic bone marrow transplantation is a curative intervention for both neoplastic and non-malignant conditions. However, not all patients have an HLA-matched donor. Therefore, the development of an approach that expand the donor pool was of paramount relevance. The development of post-transplantation cyclophosphamide as graft versus host disease prophylaxis allows the safe use of haploidentical donors, solving the donor availability problem to the vast majority of patients in need. The present paper reviews the history of the development of haploidentical transplantation at Johns Hopkins University, from the bench to the bedside.

Keywords

• Haploidentical
• HLA-matched
• bone marrow transplantation
• acute graft versus host disease
• chronic graft versus host disease
• graft failure